Accelerating Small Molecule Drug Discovery Through AI/ML Integration

Join us for a two-hour seminar exploring the latest advances in small molecule drug discovery, with scientific insights, practical examples and opportunities for discussion. The session will conclude with a Q&A and informal networking event over drinks and light bites.

Date & Time:

Monday, October 5th, 2026

From 14:30 to 18:00 CET

Venue:

Pullman Basel Europe, Clarastrasse 43, 4058 Basel, Switzerland

Program:

Welcome Coffee

14:30 – 15:00

Interactive Session:

Accelerating drug discovery through AI/ML integration

15:00 – 17:00

Jean-Christophe Mozziconacci, Senior Principal Scientist, Applications Science

Amy Clarke, Senior Scientist, Applications Science

• Structurally enabling projects using cofolding methods and induced fit docking (IFD-MD)
• Hit-ID using virtual screening accelerated by active learning and de novo design workflows
• Lead optimization using predictive models, generative ML and Retrosynth integrated into LiveDesign
• Introducing Bunsen as your agentic AI co-scientist

This will be demonstrated using the p38:MK2 molecular glue discovery program from Schrödinger’s Therapeutics Group.

Discussion & Networking

17:00 – 18:00

Continue the conversation over drinks and light bites

The seminar is free to attend but pre-registration is required as seats are limited. Previous experience with the Schrödinger suite is not required.